PONATINIB AS TARGETED THERAPY FOR THE 8P11 MYELOPROLIFERATIVE SYNDROME

被引：0
|
作者：
Chase, A.
Bryant, C.
Score, J.
Cross, N.
机构：
[1] Wessex Reg Genet Lab, Salisbury, Wilts, England
[2] Univ Southampton, Salisbury, Wilts, England
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1067
引用
收藏
页码：435 / 435
页数：1
相关论文
共 50 条
  • [1] Ponatinib as targeted therapy for FGFR1 fusions associated with the 8p11 myeloproliferative syndrome
    Chase, Andrew
    Bryant, Catherine
    Score, Joannah
    Cross, Nicholas C. P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2013, 98 (01): : 103 - 106
  • [2] The 8p11 myeloproliferative syndrome: Genotypic and phenotypic classification and targeted therapy
    Li, Taotao
    Zhang, Gaoling
    Zhang, Xiaoling
    Lin, Hai
    Liu, Qiuju
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [3] The 8p11 myeloproliferative syndrome
    Reiter, A
    Hehlmann, R
    Goldman, JM
    Cross, NCP
    MEDIZINISCHE KLINIK, 1999, 94 (04) : 207 - 210
  • [4] 8p11 myeloproliferative syndrome: a review
    Jackson, Courtney C.
    Medeiros, L. Jeffrey
    Miranda, Roberto N.
    HUMAN PATHOLOGY, 2010, 41 (04) : 461 - 476
  • [5] Die 8p11-myeloproliferative ErkrankungThe 8p11 myeloproliferative syndrome
    Andreas Reiter
    Rüdiger Hehlmann
    John M. Goldman
    Nicholas C. P. Cross
    Medizinische Klinik, 1999, 94 (4) : 207 - 210
  • [6] 8p11 myeloproliferative syndrome: diagnostic challenges and pitfalls
    Antic, Darko A.
    Vukovic, Vojin M.
    Feenstra, Jelena D. Milosevic
    Kralovics, Robert
    Bogdanovic, Andrija D.
    Fekete, Marija S. Dencic
    Mihaljevic, Biljana S.
    JOURNAL OF BUON, 2016, 21 (03): : 745 - 749
  • [7] 8P11 MYELOPROLIFERATIVE SYNDROME: DIAGNOSTIC CHALLENGES AND PITFALLS
    Vukovic, V.
    Antic, D.
    Milosevic, J.
    Kralovics, R.
    Bogdanovic, A.
    Fekete, M. Dencic
    Jovanovic, M. Perunicic
    Djurasinovic, V.
    Jelicic, J.
    Mihaljevic, B.
    HAEMATOLOGICA, 2014, 99 : 663 - 664
  • [8] Molecular Monitoring of 8p11 Myeloproliferative Syndrome in an Infant
    Zhang, Wenyong W.
    Habeebu, Sultan
    Sheehan, Andrea. M.
    Naeem, Rizwan
    Hernandez, Vivian S.
    Dreyer, ZoAnn E.
    Lopez-Terrada, Dolores
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2009, 31 (11) : 879 - 883
  • [9] Primary cells in BCR/FGFR1-positive 8p11 myeloproliferative syndrome are sensitive to dovitinib, ponatinib, and dasatinib
    Landberg, Niklas
    Dreimane, Arta
    Rissler, Marianne
    Billstrom, Rolf
    Agerstam, Helena
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2017, 99 (05) : 442 - 448
  • [10] The 8p11 myeloproliferative syndrome in a 3-year-old child
    Kuskonmaz, Baris
    Kafali, Candas
    Akcoren, Zuhal
    Karabulut, Hatil G.
    Akalin, Ibrahim
    Tuncer, Murat A.
    LEUKEMIA RESEARCH, 2008, 32 (01) : 198 - 199
12345